Stephanie .

Practice Areas

Stephanie advises Indonesian business groups and growth companies, focusing on cross-border M&A and the healthcare sector.

Stephanie handles inbound investment into Indonesia, public and private M&A, and joint ventures. She advises local business groups and major foreign investors on their joint ventures, acquisitions and corporate restructurings, and growth companies on their fundraisings. She covers a broad range of sectors, with a particular focus on the healthcare sector.

Stephanie's clients include local business groups and conglomerates, blue chip multinationals, and international private equity firms. She is accustomed to dealing with international clients investing in Indonesia and providing legal advice to international standards.

Career

Stephanie joined the firm in 2009 after graduating in law from the University of Indonesia. She has a Master’s degree in International Business Law from the University of Tilburg in the Netherlands, which she obtained under a full scholarship from Erasmus Mundus. She was seconded to the Singapore office of Herbert Smith Freehills Kramer from 2016 to 2018 and is fluent in English and Bahasa Indonesia.

Publications

Stephanie has co-authored the following publications:

Update: Reforming Indonesia’s healthcare system – Key features of the health law (February 2024)

Indonesia’s venture capital landscape – Top five things to consider early on (November 2023)

Reforming Indonesia’s healthcare system – Key features of the Omnibus Health Bill (June 2023)

Capital markets and securities law reform under Indonesia’s 2023 Financial Omnibus Law (April 2023)

Dealmaking done well: A discussion with the Indonesia Investment Authority's Chief Investment Officer (December 2022)

Industry Sector Expertise

Pharmaceuticals and healthcare

Consumer

Manufacturing and industrials

Private capital

Languages Spoken

English, Indonesian

Work Highlights

Mayapada Healthcare Group, a listed healthcare group in Indonesia, on a US$157 million hybrid investment by Bain Capital into Anugerahraya Sejahteraraya Tbk involving both equity and bonds

Columbia Asia in its acquisition from TE Asia Healthcare Partners of a healthcare group operating specialty hospitals and clinics that provide oncology, cardiology and orthopaedics services across Southeast Asia

Kopi Kenangan, an Indonesian coffee shop chain, on its Series C fundraising, which made the group the first New Retail F&B Unicorn in Southeast Asia

LinkAja, the SOE-backed digital payment platform, on a strategic investment by Grab, Southeast Asia’s leading super app, in its Series B funding round, being the first investment by a major technology company in LinkAja

Silk Road Fund, a state-owned investment fund of the Chinese government, on its proposed investment into Kimia Farma

a private equity firm on a significant investment in a major Indonesian company group engaging in healthcare services, including hospitals, laboratories and clinics, structured through a combination of loans, options and convertible bonds

Tunggal Group, a leading Indonesian pharmaceuticals group, on its sale in PT Aventis Pharma alongside Sanofi to PT Kalbe Farma Tbk

PT Omni Healthcare, an Indonesian hospital group, on the sale of its controlling stake in hospital operator PT Sarana Meditama Metropolitan Tbk to PT Elang Mahkota Teknologi Tbk (Emtek), one of Indonesia’s largest media and tech solutions companies, which has been expanding its portfolio to include healthcare operations

Education